A critical breakthrough in cancer investigation is emerging with the use of mini-antibodies to re-engage mutated p53. This essential malignant inhibitor protein is frequently inactivated in many forms of malignancies, https://bookmarketmaven.com/story22853049/mini-antibodies-revive-tumor-suppressor-p53-the-promising-pathway-for-malignant-therapy